MAgna GraecIa Evaluation of Comorbidities in Patients With Heart Failure STUDY

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-11-01

Study Completion Date

2024-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The MAGIC-HF STUDY project (MAgna GraecIa evaluation of Comorbidities in patients with Heart Failure STUDY), is an observational prevalence and incidence study focusing on the role that risk factors, various comorbidities, and their treatment may have on CV and non-CV outcomes in patients with all forms of HF. It also aim to assess whether comorbidities and their treatment may be predictors of response to pharmacological and non-drug treatment of HF.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prognostic Impact of Noncardiac Comorbidities in Heart Failure Patients

NCT02946476

Heart Failure, Diastolic Heart Failure, Systolic

COMPLETED

Incidence and Echocardiographic Predictors of HFpEF in High-Risk Population Afferent to Italian Echo-labs Network

NCT05753553

Heart Failure Heart Failure With Preserved Ejection Fraction

UNKNOWN

BLITZ Heart Failure

NCT03661060

Heart Failure

COMPLETED

Study of the Prognosis of Patients With Heart Failure With Preserved Ejection Fraction

NCT05496439

Heart Failure With Preserved Ejection Fraction

COMPLETED

Artificial Intelligence and Smart Wearable Technologies for Early Detection of Acute Heart Failure

NCT05591443

Heart Failure，Congestive

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Adult subjects with all forms of HF (HFrEF, HFmrEf, HEpEF) with at least one comorbidity who are referred to the Heart Failure Outpatient Clinic of the AOU "Mater Domini" Geriatrics Unit in Catanzaro will be recruited.

Initially, patients will be evaluated at baseline and followed-up for a minimum of six-month.

All patients will be subjected to clinical, instrumental and laboratory examinations, including medical history data collection and complete anthropometric assessment . Plasma and serum samples will be collected at recruitment and at the six-months follow-up visit. Stool samples will also be obtained and stored at -80C for the omics studies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HF patients

Adult subjects with all forms of HF will be recruited

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Informed Consent obtained before performing any procedure
* Age\>18 years old
* Confirmed diagnosis of HFrEF, HFmrEF, HFpEF with clinical stability for at least 4 weeks
* Presence of at least one of the following comorbidities:
* Atrial fibrillation
* Peripheral arteriopathy
* Hypertension
* Chronic ischemic heart disease
* Diabetes mellitus type 2 or insulin resistance
* Hepatopathy
* Obesity
* Cancer
* Sleep apnea syndrome
* Chronic kidney disease
* Iron deficiency
* Cognitive Decline or Depression
* Sarcopenia
* Dysthyroidisms
* Hypovitaminosis D
* Hyperuricemia

Exclusion Criteria

* Liver cirrhosis Child-Pugh C
* Severe chronic renal failure defined by an estimated glomerular filtration rate (eGFR) value \< 15 ml/min/1.73 m2 according to CKD-EPI
* Suspected alcohol or drug abuse
* Pregnancy or breast feeding

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes